Cargando…

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer by histology: A SEER based survival analysis

To evaluate the prognostic effect of neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer (EOC) patients with different histological subtype. Stage III/IV EOC patients diagnosed between 2010 and 2018 were identified from the surveillance, epidemiology, and end results database (SEER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuexi, Ni, Meng, Huang, Fanfan, Gu, Qiuying, Xiao, Yao, Du, Xinyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5600
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875958/ https://www.ncbi.nlm.nih.gov/pubmed/36705377 http://dx.doi.org/10.1097/MD.0000000000032774

Ejemplares similares

Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer: A single-center experience
por: Liu, Yu, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

Effects of sequential paclitaxel–carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study
por: Wang, Fei, et al.
Publicado: (2016)

Comparison of secondary cytoreductive surgery plus chemotherapy with chemotherapy alone for recurrent epithelial ovarian, tubal, or peritoneal carcinoma: A propensity score-matched analysis of 112 consecutive patients
por: Takahashi, Akimasa, et al.
Publicado: (2017)

Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer: A network meta-analysis
por: Qu, Chang-Ping, et al.
Publicado: (2017)

Skin metastases in epithelial ovarian and fallopian tube carcinoma
por: Otsuka, Isao, et al.
Publicado: (2017)

Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis
por: Kim, Se Ik, et al.
Publicado: (2019)

Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer
por: Wang, Ting, et al.
Publicado: (2017)

Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis
por: Liao, Ting, et al.
Publicado: (2021)

Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer
por: Li, Yong, et al.
Publicado: (2021)

Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer
por: Zhang, Xue-ying, et al.
Publicado: (2021)

Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer
por: Zhao, Ke, et al.
Publicado: (2023)

Expression of preoperative KISS1 gene in tumor tissue with epithelial ovarian cancer and its prognostic value
por: Cao, Fang, et al.
Publicado: (2016)

Ovarian torsion of mixed epithelial tumor misdiagnosed as a malignancy in postmenopausal woman: A case report
por: Jeon, Hyeji, et al.
Publicado: (2017)

Sequential Chemotherapy and Radiotherapy in the Sandwich Method for Advanced Endometrial Cancer: A Meta-Analysis
por: Gao, Huiqiao, et al.
Publicado: (2015)

Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer
por: Zhang, Pengjun, et al.
Publicado: (2015)

The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study
por: Lee, Wen-Ling, et al.
Publicado: (2015)

Cytoreductive surgery for advanced stage ovarian cancer in the second trimester of pregnancy—a case report and literature review
por: Bacalbaşa, Nicolae, et al.
Publicado: (2020)

Hysteroscopic and aspiration biopsies in the histologic evaluation of the endometrium, a comparative study
por: Utida, Gilberto Massaki, et al.
Publicado: (2019)

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
por: Baruah, Upasana, et al.
Publicado: (2015)

Chinese herbal medicine for premature ovarian insufficiency: A protocol for systematic review
por: Shao, Yifeng, et al.
Publicado: (2020)

Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study
por: Guo, Qiufen, et al.
Publicado: (2020)

A case report of ovarian granulosa cell tumor in patient with polycystic ovarian syndrome
por: Kim, Yun S., et al.
Publicado: (2021)

Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report
por: Sun, Li, et al.
Publicado: (2020)

Effects of vitamin D supplementation on ovarian reserve markers in infertile women with diminished ovarian reserve
por: Bacanakgil, Besim Haluk, et al.
Publicado: (2022)

Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition
por: Zhang, Yan, et al.
Publicado: (2023)

The effect of salpingectomy on the ovarian reserve and ovarian response in ectopic pregnancy: A systematic review and meta-analysis
por: Luo, Jiaqi, et al.
Publicado: (2019)

Different Prognostic Implications of (18)F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer
por: Rahman, Tasmiah, et al.
Publicado: (2016)

A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate
por: Qiu, Xiaofeng, et al.
Publicado: (2021)

Ovarian metastasis in women with cervical carcinoma in stages IA to IIB: A systematic review and meta-analysis
por: Fan, Yu, et al.
Publicado: (2020)

Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis
por: Hada, Taira, et al.
Publicado: (2021)

Ovarian dysgerminoma in pregnancy: A case report
por: Sas, Ioan, et al.
Publicado: (2021)

The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
por: Zhu, Xiuxian, et al.
Publicado: (2016)

Ovarian remnant syndrome with paraintestinal ovarian serous cystadenofibroma arose 30 years after bilateral salpingo-oophorectomy: A case report
por: Tien, Chin-Tzu, et al.
Publicado: (2022)

Analysis of magnetic resonance imaging features of ovarian thecoma
por: Li, Zhi, et al.
Publicado: (2020)

Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization
por: Jiang, Shutian, et al.
Publicado: (2017)

The comparison of evaluative effectiveness between antral follicle count/age ratio and ovarian response prediction index for the ovarian reserve and response functions in infertile women
por: Zhou, Shan-Jie, et al.
Publicado: (2020)

Primary ovarian carcinoid: Two cases report and review of literature
por: Zhai, Li-Rong, et al.
Publicado: (2020)

Intrauterine device found in an ovarian tumor: A case report
por: An, Yongyu, et al.
Publicado: (2020)

Prognostic significance of lymphocyte monocyte ratio in patients with ovarian cancer
por: Cai, Linrui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_44909lcmpff82jfr7meeh7b3ra